MY33-3 (hydrochloride) is a potent and selective inhibitor of protein tyrosine phosphatase RPTPβ/ζ (IC50 ~0.1 μM) and also inhibits PTP-1B (IC50 ~0.7 μM); it reduces ethanol consumption and alleviates sevoflurane-induced neuroinflammation and cognitive dysfunction.